News | April 22, 2008

MSCT Effective In Detecting Pulmonary Embolisms without US

April 23, 2008 - In detecting pulmonary embolisms (PE), researchers found that for the detection of PE it is as effective to use D-dimer (DD) measurement in combination with multislice CT (MSCT) compared to DD venous ultrasonography (US) of the leg and MSCT, according to a study published on April 18, 2008 in The Lancet.

This could means that venous US may no longer be needed to diagnose PE when MSCT is used, the researchers said.

Detection of PE presently includes clinical probability assessment (CPA) with subsequent sequential diagnostic tests, such as the DD, US and CT scans. MSCT is able to make several images in a similar way simultaneously. MSCT has provided new potential to replace pulmonary angiography, because it allows more accurate visualization of the segmental and subsegmental vessels. D-dimer ultrasonography involves detection of a protein present in the blood after a blood clot forms.

In a study led by Marc Righini, M.D., Geneva University Hospital, and faculty of Medicine, Switzerland, researchers performed a randomized controlled trial of 1,819 outpatients who were clinically suspected of having PE. There were two strategies for diagnosis that were compared. One (DD-CT) involved 903 patients, who evaluated CPA combined with D-Dimer measurement and MSCT. The second strategy (DD-CT-US), included 916 patients, was the same but included venous ultrasonography of the leg. The effectiveness was quantified by calculating the 3-month risk of recurrent deep vein thrombosis or PE in patients who were left untreated because they had been excluded by either strategy.

The prevalence of PE was 20.6 percent in both groups. There were 186 in the DD-CT group and 189 in the DD-CT-US group. After these patients were removed from the population, 838 remained DD-CT and 855 DD-US-CT. Later examination showed the 3-month risk of PE was 0.3 percent in both groups, in other words both strategies were equally effective. Compared to the old method, which requires lung scans with nuclear medicine techniques, MSCT would be easier and more widely available to doctors.

"We conclude that ultrasound is not needed to rule out pulmonary embolism when MSCT is used. An ultrasound could be of use in patients with a contraindication to CT," they said.

For more information: www.thelancet.com/journals/lancet/article/PIIS0140673608605942/abstract

Related Content

CT Offers Non-Invasive Alternative for Complex Coronary Disease Treatment Planning based on data from the SYNTAX III Trial. The use of FFR-CT in the trial showed better planning for interventional procedures.

CT cffers a non-invasive alternative for complex coronary disease treatment planning based on data from the SYNTAX III Trial. 

News | CT Angiography (CTA) | October 16, 2018
A new study published in the European Heart Journal shows computed tomography (CT) can be a useful aid in heart team...
A comparison of CT image of heavily calcified coronary arteries that appear to present a significant hemodynamic blockages and the correspending FFR-CT showing the patient had adequate blood flow and does not need a diagnostic angiogram or intervention.

A comparison of a CT image of heavily calcified coronary arteries that appear to present a significant hemodynamic blockage and the corresponding FFR-CT showing the patient had adequate blood flow and does not need a diagnostic angiogram or intervention. Image courtesy of Kavitha Chinnaiyan, William Beaumont Hospital.

Feature | CT Angiography (CTA) | July 23, 2018 | Dave Fornell, Editor
The use of non-invasive fractional flow reserve CT (FFR-CT) was the hottest topic discussed at the Society of Cardiov
Videos | CT Angiography (CTA) | July 19, 2018
Kavitha Chinnaiyan, M.D., FACC, FSCCT, associate professor, Oakland University, William Beaumont School of Medicine,
Videos | CT Angiography (CTA) | July 18, 2018
A discussion with Gianluca Pontone, M.D., Ph.D., FSCCT, director of cardiovascular MRI, Centro Cardiologico Manzino,
Videos | CT Angiography (CTA) | July 17, 2018
A discussion with Todd Villines, M.D., FACC, FAHA, FSCCT, cardiologist, Georgetown Medical Center, and president of t
HeartFlow Announces New Commercial Coverage With UnitedHealthcare
News | CT Angiography (CTA) | July 03, 2018
HeartFlow Inc. announced that UnitedHealthcare now covers the HeartFlow FFRct Analysis, extending access to their 45...
Post-Mortem CT Angiography Illuminates Causes of Death
News | CT Angiography (CTA) | June 25, 2018
Computed tomography (CT) angiography is a useful adjunct to autopsy that is likely to increase the quality of post-...
iSchemaView Receives FDA Clearance for Rapid CTA
Technology | CT Angiography (CTA) | May 01, 2018
Cerebrovascular imaging analysis company iSchemaView received final clearance from the U.S. Food and Drug...
The use of metal artifact reduction software on this CCTA (CTA) cardiac CT from an Canon, Toshiba, Aquilion Precision, allows clear visualization inside a coronary stent. The 0.25 mm high-resolution reconstruction also helps delineate the various components of plaque.

The use of metal artifact reduction software on this Aquilion Precision image allows clear visualization inside a coronary stent. The 0.25 mm high-resolution reconstruction also helps delineate the various components of plaque.

Feature | CT Angiography (CTA) | April 26, 2018 | Dave Fornell
There have been a few big, recent advancements in cardiac computed tomography angiography (CCTA) imaging technology.
Siemens Healthineers, Florida Hospital Collaborate to Improve Healthcare Outcomes
News | CT Angiography (CTA) | January 23, 2018
January 23, 2018 – Siemens Healthineers and Florida Hospital, part of Adventist Health System, have announced a multi
Overlay Init